Autori: Legedza Anna
| Naslov | A Randomized, Double-Blind, Placebo-Controlled, Twelve-Week, Dose-Ranging Study of Decernotinib, an Oral Selective JAK-3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis (Article) |
| Autori | Fleischmann Roy M Damjanov Nemanja S Kivitz Alan J Legedza Anna Hoock Thomas Kinnman Nils |
| Info | ARTHRITIS & RHEUMATOLOGY, (2015), vol. 67 br. 2, str. 334-343 |
| Projekat | Vertex Pharmaceuticals Incorporated |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
